ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
114 hedge funds and large institutions have $728M invested in Endocyte, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
28% less call options, than puts
Call options by funds: $4.41M | Put options by funds: $6.12M
Holders
114
Holding in Top 10
3
Calls
$4.41M
Puts
$6.12M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$24.4M | |
| 3 | +$21.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$20.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$13.6M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$13.6M | |
| 3 | -$12.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.76M |